Skip to main content
Anthem Biosciences Limited logo

Anthem Biosciences Limited — Investor Relations & Filings

Ticker · ANTHEM ISIN · INE0CZ201020 LEI · 335800FNA941U9NMD221 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 84 across all filing types
Latest filing 2025-08-13 Regulatory Filings
Country IN India
Listing BSE.NS ANTHEM

About Anthem Biosciences Limited

https://anthembio.com/

Anthem Biosciences Limited is a comprehensive Contract Research and Manufacturing Services (CRAMS) organization providing integrated solutions across the drug discovery and development lifecycle. The company offers services including medicinal chemistry, process research, analytical validation, and large-scale commercial manufacturing. Its technical expertise spans synthetic organic chemistry, fermentation technology, molecular biology, and cell biology, enabling the production of both small molecules and biologics. Anthem serves global clients in the pharmaceutical, biopharmaceutical, and specialty chemical sectors. The organization features state-of-the-art research facilities and cGMP-compliant manufacturing units, facilitating a seamless transition from initial concept to market-ready products. Its commitment to intellectual property protection and rigorous quality management systems underpins its collaborative partnerships.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2025-08-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an announcement dated August 8, 2025, informing stock exchanges about the schedule of an earnings conference call for the quarter ended June 30, 2025. It includes details about the call timing, participants, and dial-in information. The document does not contain any financial results or substantive financial data itself, but rather serves to notify about the upcoming earnings call event. This fits the definition of a Call Transcript (CT) announcement or invitation rather than the transcript itself. However, since it is only an announcement of the earnings call schedule and not the transcript, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement under SEBI regulations about the earnings call schedule, not the call transcript itself.
2025-08-08 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-08-08 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal notification addressed to stock exchanges about an upcoming Board Meeting scheduled to consider and approve the unaudited financial results for the quarter ended June 30, 2025. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 29, which pertains to board meeting intimation. The document does not contain any financial data or results itself, nor does it include detailed financial analysis or reports. It is a short notice informing about the meeting date and trading window closure. Therefore, it is an announcement related to board/management activities, specifically a Board Meeting Intimation, which falls under Board/Management Information (MANG). The document length is short (1830 characters), and it is not a report or transcript but a regulatory announcement of a board meeting.
2025-08-08 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the appointment and continuation of a Registrar & Share Transfer Agent for the company, Anthem Biosciences Limited. It references compliance with a specific regulation (Regulation 7(1) of SEBI Listing Obligations) but does not contain any financial data, report, or detailed disclosures. The document length is only 1700 characters, which is quite short and does not constitute a full report or detailed announcement. It is an official regulatory announcement to stock exchanges for record-keeping and dissemination. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-07-21 English
Updates
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the appointment and continuation of a Compliance Officer under a specific regulation (Regulation 6(1) of SEBI Listing Obligations and Disclosure Requirements). It does not contain financial data, audit information, or any report content. It is an announcement about a management/board-related change, specifically the appointment of a Compliance Officer, which falls under management information disclosures. The document length is short and it is not a report or announcement of a report publication. Therefore, the most appropriate classification is Board/Management Information (MANG).
2025-07-21 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.